Our most recent articles

Melatonin may reduce the risk of prostate cancer

Melatonin level may influence the likelihood of being affected by prostate cancer. In fact, a high concentration of this hormone, known for its effects on the regulation of sleep-wake cycles, appears to be able to reduce the risk of developing advanced prostate cancer by 75 percent. 

Breast cancer: running reduces mortality in women survivors of the disease

Running protects against breast cancer more than walking. In fact, in women who have had surgery and survived cancer, running reduces the risk of mortality by more than 40 percent. An American study reveals this, thus correcting the indications of previous research, which recommended moderate physical activity such as walking. 

EFSA declares: there is no relationship between EPA, DHA and prostate cancer

There is no scientific evidence for an association between EPA (eicosapentaenoic acid), DHA (docosahexaenoic acid) and prostate cancer risk. So says the European Food Safety Agency (EFSA) in a document that also confirms the safety of Omega three, and the possibility of increasing the maximum daily intake of the EPA- and DHA-rich oil extracted from Schizochytrium seaweed, for the adult population.  

Prostate cancer: chance of survival is lower when vitamin D is low

There appears to be an association between high levels of vitamin D in the blood and an increased likelihood of surviving prostate cancer. Men with a higher concentration of the vitamin, measured before the disease was diagnosed, show a 28 percent lower risk of dying, compared with those with lower concentrations. 

Gastrointestinal tract cancer: omega-3 supplementation reduces hospitalization time after surgery

In patients with cancer of the gastrointestinal tract and undergoing surgery, omega-3 supplements stimulate immune function, reduce inflammation, and improve nutritional status, thereby facilitating recovery and reducing hospitalization time. 

Fish oil improves effectiveness of chemotherapy

Fish oil, a rich source of omega-3 fatty acids, helps counteract weight loss and improves therapeutic efficacy during chemotherapy. In particular, it is eicosapentaenoic fatty acid (EPA) that helps cancer sufferers prevent both muscle mass loss and fat loss.

Omega-6 versus Omega-3: linoleic acid promotes cancer development

A diet high in linoleic acid, a well-known omega-6 fatty acid, can promote the growth of tumor masses. This was shown in a study published in the pages of the British Journal of Cancer, the result of research by experts from the Laboratory of Molecular Carcinogenesis at the National Institutes of Health and the Osaka City University Graduate School of Medicine.

Omega-3s kill chronic myeloid leukemia stem cells

An eicosapentaenoic acid (EPA) derivative, Omega 3 contained in fish oil, kills stem cells that cause chronic myeloid leukemia.

SEARCH BY TOPIC

Melatonin may reduce the risk of prostate cancer

Melatonin level may influence the likelihood of being affected by prostate cancer. In fact, a high concentration of this hormone, known for its effects on the regulation of sleep-wake cycles, appears to be able to reduce the risk of developing advanced prostate cancer by 75 percent. 

Breast cancer: running reduces mortality in women survivors of the disease

Running protects against breast cancer more than walking. In fact, in women who have had surgery and survived cancer, running reduces the risk of mortality by more than 40 percent. An American study reveals this, thus correcting the indications of previous research, which recommended moderate physical activity such as walking. 

EFSA declares: there is no relationship between EPA, DHA and prostate cancer

There is no scientific evidence for an association between EPA (eicosapentaenoic acid), DHA (docosahexaenoic acid) and prostate cancer risk. So says the European Food Safety Agency (EFSA) in a document that also confirms the safety of Omega three, and the possibility of increasing the maximum daily intake of the EPA- and DHA-rich oil extracted from Schizochytrium seaweed, for the adult population.  

Prostate cancer: chance of survival is lower when vitamin D is low

There appears to be an association between high levels of vitamin D in the blood and an increased likelihood of surviving prostate cancer. Men with a higher concentration of the vitamin, measured before the disease was diagnosed, show a 28 percent lower risk of dying, compared with those with lower concentrations. 

Gastrointestinal tract cancer: omega-3 supplementation reduces hospitalization time after surgery

In patients with cancer of the gastrointestinal tract and undergoing surgery, omega-3 supplements stimulate immune function, reduce inflammation, and improve nutritional status, thereby facilitating recovery and reducing hospitalization time. 

Fish oil improves effectiveness of chemotherapy

Fish oil, a rich source of omega-3 fatty acids, helps counteract weight loss and improves therapeutic efficacy during chemotherapy. In particular, it is eicosapentaenoic fatty acid (EPA) that helps cancer sufferers prevent both muscle mass loss and fat loss.

Omega-6 versus Omega-3: linoleic acid promotes cancer development

A diet high in linoleic acid, a well-known omega-6 fatty acid, can promote the growth of tumor masses. This was shown in a study published in the pages of the British Journal of Cancer, the result of research by experts from the Laboratory of Molecular Carcinogenesis at the National Institutes of Health and the Osaka City University Graduate School of Medicine.

Omega-3s kill chronic myeloid leukemia stem cells

An eicosapentaenoic acid (EPA) derivative, Omega 3 contained in fish oil, kills stem cells that cause chronic myeloid leukemia.

Omega-3s from fish oil reduce colon inflammation

A low dosage of fish oil containing Omega 3 reduces inflammation levels and improves nutritional status in colon cancer sufferers.